Assyro AI

FDA Orange Book · active-ingredient family

Beclomethasone dipropionate monohydrate

Beclomethasone dipropionate monohydrate is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:BECONASE AQ · NDA 019389

3

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · spray, metered

ProductApplicantApplicationTEApproved
BECONASE AQRLDGLAXOSMITHKLINENDA 019389Jul 27, 1987
VANCENASE AQSCHERINGNDA 020469Jun 26, 1996
VANCENASE AQSCHERINGNDA 019589Dec 23, 1987

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Beclomethasone dipropionate monohydrate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.